Navigation Links
Emageon Reports Fourth Quarter and 2007 Financial Results

Company Provides Financial Guidance for 2008

BIRMINGHAM, Ala., Feb. 20 /PRNewswire-FirstCall/ -- Emageon Inc. (Nasdaq: EMAG) today reported financial results for its fourth quarter and full year ended December 31, 2007.

Revenue for the fourth quarter was $28.6 million, a 14.7% decrease from fourth quarter 2006 revenue of $33.5 million. The net loss for the quarter was $0.5 million, or $0.02 per share. In the fourth quarter of 2006, the Company earned net income of $2.1 million, or $0.10 per diluted share. For the year ended December 31, 2007, revenue was $104.2 million, a decrease of 15.6% from the comparable prior year period. Net loss for the year ended December 31, 2007 was $6.9 million, or $0.32 per share, compared to a net loss of $6.0 million, or $0.29 per share, for the year ended December 31, 2006.

Included in the Company's results of operations for 2007 are fourth quarter expenses of $1.1 million, or $0.05 per share, related to employee severance and associated expenses ($2.1 million, or $0.10 per share, for the year ended December 31, 2007), and included in the Company's results of operations for 2006 are fourth quarter expenses of $1.0 million, or $0.05 per share, related to the integration of an acquired company into the Company's operations ($5.4 million, or $0.26 per share, for the year ended December 31, 2006).

The company's cash earnings, which are determined by excluding non-cash charges for depreciation expense, amortization of intangible assets, and stock-based compensation expense from earnings determined under generally accepted accounting principles ("GAAP"), were $2.7 million, or $0.13 per diluted share, in fourth quarter 2007 compared to $6.1 million, or $0.28 per diluted share, in fourth quarter 2006. For the year ended December 31, 2007, the Company's cash earnings were $5.4 million, or $0.25 per diluted share, compared to $9.4 million, or $0.43 per diluted share, for the year ended December 31, 2006. These measures of earnings were not determined in accordance with GAAP. A reconciliation of earnings determined under GAAP to cash earnings is included below. Management believes that its cash earnings measurement, when viewed in addition to the Company's reported GAAP results, provides an additional meaningful measure of operating performance, enabling investors to more thoroughly evaluate current performance in comparison to past performance. This information will necessarily differ from comparable information that may be provided by other companies and should not be considered in isolation or as an alternative to the Company's operating and other financial information determined under GAAP.

At December 31, 2007, unrestricted cash and cash equivalents totaled $17.0 million compared to $23.0 million at December 31, 2006. The company has not drawn on its $15.0 million line of credit arrangement and has total debt obligations of less than $0.1 million. Net cash generated by operating activities was $0.8 million for the fourth quarter of 2007. For the year ended December 31, 2007, net cash consumed by operating activities was $1.0 million.

Total bookings, which include both system sales and support services orders, were $92.7 million for the year ended December 31, 2007 compared to $122.2 million for the year ended December 31, 2006. Fourth quarter 2007 total bookings were $34.5 million compared to $33.7 million in fourth quarter 2006. At December 31, 2007, total orders backlog was $147.8 million, of which $130.1 million are support service orders.

The Company has also announced financial guidance for its year ending December 31, 2008. The company anticipates total bookings in the range of $65.0 to $70.0 million, revenue in the range of $87.0 to $89.0 million, net loss in the range of $4.3 to $4.9 million, or $0.20 to $0.23 per share, and cash earnings, a non-GAAP measure, in the range of $4.9 to $5.8 million, or $0.23 to $0.27 per share. See "Forward Looking Statements" below.

"While 2007 proved to be a difficult year for our business, we were pleased to close the year with our strongest quarter," said Chuck Jett, Chairman and CEO of Emageon. "The market for image management systems, especially in the large hospital sector, is now heavily penetrated, and we expect to see additional challenges in new system sales in 2008. However, we have relationships with over 500 hospitals that use our solutions, and our recurring revenue from these relationships will allow us to fund investments in 2008 that will position us well as market demands change and grow and as a new market cycle evolves."

Conference Call. Emageon will host a conference call for investors on February 21, 2008, at 8:30 A.M. EST to discuss its financial results for the quarter. The call will be webcast by Thomson/CCBN and can be accessed at Emageon's web site at The dial-in telephone number for the call is 888-679-8033 (internationally, at 617-213-4846), passcode 49008180. Replay is available from 10:30 A.M. EST, February 21, 2008 until 11:59 P.M. EST, March 2, 2008 at 888-286-8010 (internationally, at 617-801-6888), passcode 11893635.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (

Forward Looking Statements. This press release contains forward-looking statements about Emageon that represent the Company's current views with respect to, among other things, future events and financial performance. Any forward-looking statements contained in this press release are based on Emageon's historical performance and on current plans, beliefs and expectations. Actual results may differ materially from those expressed or implied by such forward-looking statements as a result of various risks, uncertainties and other factors beyond its control. These risks, uncertainties and other factors include, among others, the risk that negative industry or market trends could adversely affect system sales, the risk that it may not compete successfully against larger competitors, risks associated with its history of operating losses, the risk of loss of its senior executive management, risk associated with expansion of its market and selling efforts into new product segments, the risk that its target markets do not develop as expected, the risk that it may not manage its growth effectively, the risk that its acquisition strategy may fail or that acquisitions could result in integration difficulties, dilution or other adverse financial consequences, the risk of failure to raise additional capital on acceptable terms, risks associated with its reliance on continuing relationships with large customers, the risk of significant product errors or product failures, the risk of its reliance on reseller arrangements for important components of its solution, the risk that it may not respond effectively to changes in its industry, the risk of its customers' reliance on third party reimbursements, and the risk of the potential impact on its business of Food & Drug Administration (FDA) regulations and other applicable health care regulations. Additional information concerning these and other factors that could affect Emageon's financial and operating results may be found under the heading "Risk Factors" and elsewhere in the Company's Form 10-K for the year ended December 31, 2006, which was filed with the Securities and Exchange Commission on March 16, 2007. Emageon undertakes no obligation to update these forward-looking statements or other information provided in this press release except as may be required by law.

About Emageon Inc. Emageon provides information technology systems for hospitals, healthcare networks and imaging facilities. Its enterprise family of solutions includes RadSuite(TM), HeartSuite(TM) and other specialty suites. All Emageon solutions are built on a unified Enterprise Content Management system offering advanced visualization and infrastructure tools for the clinical analysis and management of digital medical images, reports and associated clinical content. Emageon's standards-based solutions are designed to help customers enhance patient care, automate workflow, lower costs, improve productivity and provide better service to physicians. For more information, please visit

Unaudited Statements of Operations

In Thousands, Except Per Share Amounts

Three Months Ended Year Ended

December 31, December 31,

2007 2006 (1) 2007 2006 (1)


System sales $15,345 $21,100 $50,954 $75,340

Support services 13,210 12,377 53,255 48,165

Total revenue 28,555 33,477 104,209 123,505

Cost of revenue:

System sales 7,104 9,360 28,463 43,333

Support services 6,779 5,392 28,144 24,331

Total cost of revenue 13,883 14,752 56,607 67,664

Gross profit 14,672 18,725 47,602 55,841

Operating expenses:

Research and development 4,754 4,605 20,030 17,368

Sales and marketing 5,210 5,433 18,202 18,459

General and administrative 3,792 4,344 13,134 17,028

Amortization of intangible assets

related to Camtronics acquisition 345 885 1,381 3,540

Integration costs related to

Camtronics acquisition - 1,026 - 5,369

Employee severance and related

charges 1,125 - 2,120 -

Loss on disposal of property and

equipment 79 453 407 437

Total operating expenses 15,305 16,746 55,274 62,201

Operating (loss) income (633) 1,979 (7,672) (6,360)

Interest income 197 182 908 655

Interest expense (24) (70) (99) (327)

Net (loss) income $(460) $2,091 $(6,863) $(6,032)

Net (loss) income per share, basic $(0.02) $0.10 $(0.32) $(0.29)

Net (loss) income per share, diluted $(0.02) $0.10 $(0.32) $(0.29)

Weighted average shares outstanding,

basic 21,414 21,197 21,360 20,919

Weighted average shares outstanding,

diluted 21,414 21,689 21,360 20,919

(1) Certain reclassifications have been made to prior year operating

expenses to conform with the current year presentation.

Summary Consolidated Balance Sheets

In Thousands


December 31, December 31,

2007 2006


Current assets:

Cash and cash equivalents $17,034 $23,008

Trade accounts receivable, net 27,974 26,706

Inventories 6,241 8,579

Prepaid expenses and other current assets 4,726 4,459

Total current assets 55,975 62,752

Property and equipment, net 15,289 18,362

Restricted cash 1,000 445

Other noncurrent assets 2,334 1,363

Intangible assets, net 27,696 30,090

Total Assets $102,294 $113,012


Current liabilities:

Accounts payable and accrued expenses $16,023 $16,454

Deferred revenue 17,052 23,953

Current portion of long-term debt

and capital lease obligations 36 953

Total current liabilities 33,111 41,360

Long-term deferred revenue 6,146 5,851

Other long-term liabilities 466 686

Long-term portion of capital lease obligations 53 8

Total liabilities 39,776 47,905

Stockholder's equity 62,518 65,107

Total Liabilities and Stockholders'

Equity $102,294 $113,012

Reconciliation of Non-GAAP Measure of Earnings

In Thousands, Except Per Share Amounts


The following tables present the Company's net loss or income adjusted for non-cash charges for depreciation, amortization of intangible assets, and stock-based compensation ("cash earnings") for the three month periods and the years ended December 31, 2007 and 2006. Earnings determined in this manner do not represent earnings in accordance with generally accepted accounting principles ("GAAP").

The tables present the adjustments made to actual net loss or income determined under GAAP to derive cash earnings for the periods presented.

Three Months Ended December 31,

2007 2006

Net (loss) income, as reported $(460) $2,091


Depreciation 1,277 1,670

Amortization 764 1,292

Stock-based compensation 1,122 1,082

Net income exclusive of non-cash

expenses $2,703 $6,135

Net income per share exclusive of

non-cash expenses, basic $0.13 $0.29

Net income per share exclusive of

non-cash expenses, diluted $0.13 $0.28

Weighted average shares outstanding,

basic 21,414 21,197

Weighted average shares outstanding,

diluted 21,556 21,689

Year Ended December 31,

2007 2006

Net loss, as reported $(6,863) $(6,032)


Depreciation 6,024 6,990

Amortization 3,054 4,969

Stock-based compensation 3,213 3,430

Net income exclusive of non-cash

expenses $5,428 $9,357

Net income per share exclusive of

non-cash expenses, basic $0.25 $0.45

Net income per share exclusive of

non-cash expenses, diluted $0.25 $0.43

Weighted average shares outstanding,

basic 21,360 20,919

Weighted average shares outstanding,

diluted 21,753 21,541

SOURCE Emageon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008
2. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
3. Emageon to Present at the 26th Annual JPMorgan Healthcare Conference
4. Emageon Names Chris E. Perkins as Chief Operating Officer
5. Emageon Reports Third Quarter 2007 Financial Results
6. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
7. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
8. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
9. Cambrex Reports Fourth Quarter and Full-Year 2007 Results
10. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
11. TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year
Post Your Comments:
(Date:10/13/2015)... ... 2015 , ... Tempe Dental Care, a leading Tempe dentists’ office, celebrates offering ... dentistry for more than 5 years. A leading cause of emergency room visits, ... treatment is not timely. , Sedation dentistry provides an anxiety-free dental ...
(Date:10/13/2015)... ... ... According to an ESPN report published on October 1, Chicago ... him in the left eye during the first day of practice for the season ... of setbacks, including a knee injury that has interfered with his ability to stay ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... developed valuable new strategies for enrolling and serving insurance consumers who do not ... health insurance and pay monthly premiums. In “Health Plan Engagement Strategies: The ABCs ...
(Date:10/13/2015)... ... October 13, 2015 , ... Just under three months ... eMarketing Concepts began a $1 promotion – effectively offering all of their services for ... within weeks the company was flooded with phone calls from interested buyers. As a ...
(Date:10/13/2015)... ... , ... The Bill Howe Family of Companies is an award winning HVAC ... remediation services. Family-owned and operated for 35 years, they have maintained value, ethics and ... two years in a row from the Union Tribune Reader’s Poll, a Healthiest Company ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... 2015 Given the intricacy of the ... to deliver an ophthalmic drug effectively to a specific ocular ... ocular drug delivery. These include dilution of a drug by ... conjunctiva and drug permeation issues with respect to the cornea, ... eye drops, is lost due to the aforementioned barriers. ...
(Date:10/12/2015)... N.J. , Oct. 12, 2015  Shareholder rights ... a securities fraud class action complaint was filed in ... Jersey.  The complaint alleges that officers and directors of ... Act of 1934 between September 15, 2015 and October ... about Amicus Therapeutics, business prospects.  Amicus is a biopharmaceutical ...
(Date:10/12/2015)... 12, 2015  Millions of smokers worldwide have used ... of tobacco. An April 2015 study released ... showed electronic cigarettes to be up to 95 percent ... a decade after the technology was first introduced the ... --> --> Palm ...
Breaking Medicine Technology: